Cryo-Cell International, Inc. (CCEL)
Company Info
| ISIN | US2288951088 |
|---|---|
| CUSIP | 228895108 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
Highlights
| Market Cap | $61.82M |
|---|---|
| EPS | -$1.14 |
| PE Ratio | 17.12 |
| Revenue (TTM) | $31.34M |
| Gross Profit (TTM) | $21.54M |
| EBITDA (TTM) | $1.15M |
| Year Range | $3.00 - $8.15 |
| Target Price | $8.00 |
| Short % | 0.48% |
| Short Ratio | 2.23 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Cryo-Cell International, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Cryo-Cell International, Inc. had a return of 17.39% year-to-date (YTD) and 88.17% in the last 12 months. Over the past 10 years, Cryo-Cell International, Inc. had an annualized return of 16.30%, outperforming the S&P 500 benchmark which had an annualized return of 10.43%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 17.39% | 5.29% |
| 1 month | 16.58% | -2.47% |
| 6 months | 45.79% | 16.40% |
| 1 year | 88.17% | 20.88% |
| 5 years (annualized) | 2.33% | 11.60% |
| 10 years (annualized) | 16.30% | 10.43% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -9.39% | -0.19% | 43.46% | |||||||||
| 2023 | -12.26% | -0.19% | 1.90% | 7.48% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Cryo-Cell International, Inc.(CCEL)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Cryo-Cell International, Inc. (CCEL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Cryo-Cell International, Inc. granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.
| Period | TTM | 2023 | 2022 |
|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.90 |
Dividend yield | 0.00% | 0.00% | 21.28% |
Monthly Dividends
The table displays the monthly dividend distributions for Cryo-Cell International, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | |||||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.90 | $0.00 | $0.00 | $0.00 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Cryo-Cell International, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cryo-Cell International, Inc. was 96.67%, occurring on Nov 18, 2008. Recovery took 2773 trading sessions.
The current Cryo-Cell International, Inc. drawdown is 45.70%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.67% | Mar 6, 2000 | 2169 | Nov 18, 2008 | 2773 | Sep 1, 2021 | 4942 |
| -92.13% | Jan 22, 1997 | 403 | Oct 8, 1998 | 287 | Nov 30, 1999 | 690 |
| -85.29% | Jul 28, 1995 | 56 | Dec 5, 1995 | 74 | Apr 30, 1996 | 130 |
| -76.11% | Sep 3, 2021 | 391 | Mar 28, 2023 | — | — | — |
| -48.54% | Jun 6, 1996 | 137 | Dec 26, 1996 | 13 | Jan 15, 1997 | 150 |
Volatility
Volatility Chart
The current Cryo-Cell International, Inc. volatility is 21.28%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |